|Mr. Alvaro Francisco Torres||Co-Founder, CEO & Director||283.95k||N/A||1979|
|Mr. Joel Friedman||Chief Financial Officer||187.26k||N/A||N/A|
|Mr. Tejinder Virk||Pres & MD of Khiron Europe||1.25M||N/A||N/A|
|Mr. Manuel Buendia||VP of Operations||N/A||N/A||N/A|
|Mr. Matt Murphy||VP of Compliance||N/A||N/A||1962|
|Ms. Livia M. Maduri||Gen. Counsel & Corp. Sec.||N/A||N/A||N/A|
|Jon Packer||VP of Communications||N/A||N/A||N/A|
|Mr. Luis Chavez||Country Mang. of Mexico||N/A||N/A||N/A|
|Mr. Marco Algorta||Country Mang. of Uruguay||N/A||N/A||N/A|
|Ms. Franziska Katterbach||Chief Legal Officer & MD of Khiron Europe||N/A||N/A||N/A|
Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America, North America, and Europe. It operates through three segments: Medical Cannabis Products, Health Services, and Wellbeing Products. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and CBD (cannabidiol) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. is based in Vancouver, Canada.
Khiron Life Sciences Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.